Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 DKK)

Closing information 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 355,527 Less Arrow 280,309 More Arrow 307,150
Financial expenses 27,090 Less Arrow 11,196 Less Arrow 6,338
Earnings before taxes -59,356 More Arrow -13,797 More Arrow 26,683
EBITDA -18,131 More Arrow 12,800
Total assets 355,936 More Arrow 413,118 Less Arrow 371,928
Current assets 270,829 More Arrow 332,943 Less Arrow 275,541
Current liabilities 133,358 More Arrow 332,301 Less Arrow 157,122
Equity capital -27,416 More Arrow 64,494 More Arrow 80,169
- share capital 14,208 More Arrow 15,694 More Arrow 15,997
Employees (average) 128 Less Arrow 124 More Arrow 129

Financial ratios

Fiscal year 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency -7.7% More Arrow 15.6% More Arrow 21.6%
Turnover per employee 2,778 Less Arrow 2,261 More Arrow 2,381
Profit as a percentage of turnover -16.7% More Arrow -4.9% More Arrow 8.7%
Return on assets (ROA) -9.1% More Arrow -0.6% More Arrow 8.9%
Current ratio 203.1% Less Arrow 100.2% More Arrow 175.4%
Return on equity (ROE) 216.5% Less Arrow -21.4% More Arrow 33.3%
Change turnover 101,766 Less Arrow -21,027 More Arrow 25,586
Change turnover % 40% Less Arrow -7% More Arrow 9%
Chg. No. of employees 4 Less Arrow -5 Less Arrow -20
Chg. No. of employees % 3% Less Arrow -4% Less Arrow -13%

Total value of public sale

Fiscal year 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.